In the early months of 2021, a World Obesity Federation study placed a quiet but consequential mirror before the world's wealthiest nations: the countries that had struggled longest with obesity were also the ones burying the most of their dead from COVID-19. Of the 2.5 million lives lost to the pandemic by that point, 2.2 million belonged to high-obesity nations — a correlation so consistent across borders that researchers could no longer treat it as coincidence. The study invited a deeper reckoning, not only with a virus, but with the accumulated costs of how modern societies have chosen to
RT en Español
· Mar 06, 2021
· health
· 2 min de leitura
Medium
Apuração: Caracterizado
Study links obesity rates to COVID-19 mortality across nations
2.2 million of 2.5 million total COVID-19 deaths occurred in high-obesity countries, with obese individuals facing higher hospitalization and critical care risks.
◉
Health & Medicine
2798 artigos relacionados
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% correspondência
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% correspondência
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% correspondência
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% correspondência
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% correspondência
Cobertura Relacionada
El País · Aug 22
La personalidad Ozempic: cómo la delgadez extrema acaba con el placer
Usuarios de fármacos GLP-1 como Ozempic reportan anhedonia, un efecto secundario que les impide disfrutar de actividades…
CNN en Español · Aug 22 Moderna y Merck logran avance decisivo con vacuna personalizada contra el cáncerMerck y Moderna reportan éxito de una vacuna personalizada contra el melanoma que entrena el sistema inmunológico para a…
El Divisadero · Aug 21 Hepatitis virales: herramientas de prevención y cura al alcance en AysénGastroenterólogo del Hospital Regional Coyhaique explica las hepatitis virales, sus formas de transmisión y las herramie…
radiosantamaria.cl · Aug 21 Escuela España suspende clases por brote de enfermedades respiratorias en CoyhaiqueLa Escuela Diferencial España de Coyhaique suspendió clases por 48 horas tras confirmarse un brote de enfermedades respi…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Public health study correlates obesity rates with COVID-19 mortality; no direct geopolitical implications but highlights healthcare disparities between developed and East Asian nations.
Escalation Risk
low
Confidence
MED
United States
United Kingdom
European Union
Japan
South Korea
Indirectly reinforces East Asian (Japan, South Korea) public health governance models as superior to Western approaches; may influence global health policy discourse and soft power narratives around pandemic preparedness.
Similar to post-SARS comparisons that elevated East Asian epidemiological credibility; echoes Cold War-era health outcome comparisons used to validate competing systems.
Lente Econômica
📈
Study correlates high obesity rates with elevated COVID-19 mortality, showing 10x higher death rates in nations where 50%+ adults are overweight, with implications for public health spending and healthcare system capacity.
Market Signal
mixed
Confidence
MED
Healthcare and pharmaceuticals
Public health services
Health insurance and medical devices
Food and beverage industry
Fitness and wellness services
Government social services
Consumers in high-obesity nations face increased healthcare costs, insurance premiums, and potential health restrictions. May drive demand for weight-loss products, fitness services, and preventive healthcare. Could lead to food industry regulation and taxation on unhealthy products.
Governments likely to implement obesity prevention policies including sugar taxes, food labeling regulations, healthcare subsidies for weight management, and public health campaigns. May increase healthcare budgets for obesity-related complications. Potential regulatory pressure on food manufacturers and marketing practices targeting unhealthy products.